Marshall S. Stanton Artivion, Inc. (AORT) insider trading activity

Marshall S. Stanton is SVP, Clinical & MD Affair of ARTIVION, INC.. Currently has a direct ownership of 64,200 shares of AORT, which is worth approximately $2.1 Million. The most recent transaction as insider was on Jun 17, 2025, when has been sold 15,000 shares (Common Stock) at a price of $29.5 per share, resulting in proceeds of $442,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 64.2K

39.05% 3M change

22.93% 12M change

Total Value Held $2.1 Million

Marshall S. Stanton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 17 2025	SELL Open market or private sale	$442,500 $29.5 p/Share	15,000 Reduced 18.94%	64,200 Common Stock
Jun 13 2025	SELL Open market or private sale	$743,455 $28.45 p/Share	26,132 Reduced 24.81%	79,200 Common Stock
May 09 2025	SELL Open market or private sale	$307,263 $29.13 p/Share	10,548 Reduced 9.1%	105,332 Common Stock
Mar 06 2025	SELL Open market or private sale	$39,754 $24.8 p/Share	1,603 Reduced 1.36%	115,880 Common Stock
Mar 06 2025	BUY Grant, award, or other acquisition	-	19,240 Added 14.07%	117,483 Common Stock
Feb 28 2025	BUY Grant, award, or other acquisition	-	18,398 Added 15.77%	98,243 Common Stock
Feb 24 2025	SELL Open market or private sale	$128,001 $27.31 p/Share	4,687 Reduced 5.54%	79,845 Common Stock
Mar 20 2024	SELL Open market or private sale	$44,511 $20.39 p/Share	2,183 Reduced 2.55%	83,296 Common Stock
Mar 05 2024	SELL Open market or private sale	$28,192 $18.72 p/Share	1,506 Reduced 1.73%	85,438 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	5,724 Added 6.18%	86,944 Common Stock
Feb 27 2024	SELL Open market or private sale	$9,220 $19.83 p/Share	465 Reduced 0.57%	81,220 Common Stock
Feb 26 2024	SELL Open market or private sale	$61,782 $20.27 p/Share	3,048 Reduced 3.6%	81,685 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	16,030 Added 16.17%	83,133 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	14,800 Added 17.72%	68,703 Common Stock
Mar 02 2023	SELL Open market or private sale	$12,162 $13.41 p/Share	907 Reduced 1.71%	52,077 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	3,663 Added 6.47%	52,984 Common Stock
Feb 27 2023	SELL Open market or private sale	$30,240 $12.94 p/Share	2,337 Reduced 4.52%	49,321 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	11,210 Added 18.17%	50,482 Common Stock
Nov 08 2022	BUY Grant, award, or other acquisition	-	19,447 Added 33.16%	39,195 Common Stock
Feb 23 2022	BUY Grant, award, or other acquisition	-	8,406 Added 29.86%	19,748 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$13,510 $17.5 p/Share	772 Reduced 6.37%	11,342 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	2,603 Added 17.69%	12,114 Common Stock
Mar 16 2021	BUY Grant, award, or other acquisition	-	8,511 Added 47.23%	9,511 Common Stock

MSS

Marshall S. Stanton

SVP, Clinical & MD Affair

Kennesaw, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AORT shares.

Notify only if

Value

Insider Trading

Get notified when an Artivion, Inc. insider buys or sells AORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARTIVION, INC.

Track Activities on AORT

Account